Statistics for Arecor Therapeutics plc (id:3946 AREC)

Valuation metrics

Market cap

28.88M

Enterprise value

21.16M

Trailing P/E (ttm)

-26,785.71

Forward P/E

-5.46

PEG ratio

-5.46

Price/Sales (ttm)

5.90

Price/Book (mrq)

460.84

Enterprise Value/Revenue

4.32

Enterprise Value/EBITDA

-2.38

Overview

Shares outstanding

37.76M

Float

20.44M

Shares short

% Held by insiders

0.25%

% Held by institutions

0.47%

Average volume (10 days)

10.60K

Average volume (90 days)

Price summary

52-Week low

62.55

52-Week high

199.00

52-Week change

-148.00%

Beta

-0.27

50-Day moving average

72.81

200-Day moving average

111.54

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-176.89%

Operating margin

-242.31%

Operational effectiveness

Return on assets

-37.30%

Return on equity

-94.76%

Income statement

Revenue (ttm)

0.16

Revenue per share (ttm)

0.16

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-8,881,000.00

Net income to common (ttm)

-8,666,000.00

Diluted EPS (ttm)

-0.28

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

2.54M

Total cash per share (mrq)

0.08

Total debt (mrq)

280.00K

Total Debt/Equity (mrq)

5.51

Current ratio (mrq)

136.70%

Book value per share (mrq)

0.17

Cash flow

Cash flow statement

-5,584,000.00

Levered free cash flow (LFCF)

-2,574,750.00